Skip to main content

Adam C. Lenain

Member

[email protected]

+1.858.314.1878

Share:

Adam assists life sciences and information technology companies navigate complex legal and business issues.  With a practical and creative focus on his clients’ intended business results, he often functions as an outside general counsel and is regularly consulted by management teams for guidance on strategic matters.  His clients are both public companies and emerging growth companies. 

Adam has over twenty years of experience representing issuers and investment banks in connection with public and private financing transactions, SEC regulatory compliance and ’34 Act reporting.  He also regularly represents buyers and sellers in mergers and acquisitions as well as corporations and limited liability companies with respect to general corporate issues that arise throughout the corporate life cycle--from formation to exit.

While an undergraduate at Yale, Adam played both football and baseball.  He is also an avid bass fisherman. 

Education

  • University of San Diego School of Law (JD, Magna Cum Laude)
  • Yale University (BA)

Experience

Recent Representative Transactions

  • Represented public life sciences company in a $50,000,000 follow on public offering.
  • Represent public life sciences companies in connection with ’34 Act reporting and proxy matters
  • Represented private life sciences company in a reverse merger into a Nasdaq listed public company.
  • Represented public life sciences company in a $25,000,000 PIPE transaction.
  • Represented private life sciences company in a $40,000,000 private equity financing.
  • Represented private life sciences company in a $20,000,000 private equity financing.
  • Represented private information technology company in a $8,830,000 preferred stock financing.
  • Represented private information technology company in a $4,500,000 preferred stock financing.
  • Represented private information technology company in a $28,000,000 preferred stock financing.
  • Represented private information technology company in a $4,000,000 preferred stock financing.
  • Represented private information technology company in a $5,000,000 venture debt transaction.
  • Represented private information technology company in a stock-for-stock acquisition
  • Represented private information technology company in a $1,250,000 convertible note financing.
  • Represented private information technology company in a $900,000 convertible note financing.
  • Represented private information technology company in a complex acquisition with earnout.
  • Represented private green chemistry company in a $1,000,000 line of credit transaction.
  • Represented private life sciences company in a $20,500,000 equity financing.
  • Represented private information technology company in a $1,000,000 convertible note financing.

Recognition & Awards

  • Best Lawyers in America: Corporate Law (2021)
  • Order of the Coif
  • University of San Diego Law Review editor
  • University of San Diego School of Law merit scholarship recipient

Involvement

  • Member, State Bar of California
  • Member, San Diego County Bar Association

Recent Insights

Viewpoints

News & Press

Viewpoints

Viewpoint Thumbnail

Life Sciences Newsletter — Inaugural Edition

August 20, 2020 | Article | By Adam Lenain, William Whelan, Susan Berson, Jonathan L. Kravetz, Terri Shieh-Newton

The inaugural Mintz Life Sciences Newsletter brings the latest developments in life sciences, legal insights, and industry activity straight to your inbox.
Read more

News & Press

News Thumbnail
Adam Lenain, a member of Mintz’s San Diego office, counsels technology companies, both public and private, on matters including mergers and acquisitions, licensing and collaborations, and general corporate and securities issues.
Adam Lenain, a Member in Mintz’s San Diego office, counsels technology companies, both public and private, on matters including mergers and acquisitions, licensing and collaborations, and general corporate and securities issues.
Continuing to expand its renowned life sciences platform, Mintz announced the addition of Adam Lenain as a Member in the firm’s Corporate Practice, based in San Diego.